|
⚲
|
| Keyboard |
| Stultz Katherine V
✚
|
|
|---|---|
| CIK # | 0001864500 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001864500] | |
| 4 | [0001864500] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kronos Bio Inc | |
| Stultz Katherine V | |
| LENZ Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Disposed to issuer | 34,000 | $0.00 | |
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Disposed to issuer | 7,079 | $0.00 | |
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Disposed to issuer | 68,000 | $0.00 | |
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2024-06-25 | Grant | 34,000 | $0.00 | |
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2023-06-22 | Grant | 7,079 | $0.00 | |
|
Kronos Bio Inc KRON
Director Stock Option (Right to Buy) · derivative
|
2023-04-10 | Grant | 68,000 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Common Stock
|
2021-06-29 | Conversion | 8,126 | ||
|
LENZ Therapeutics Inc GRPH
Series B Preferred Stock · derivative
|
2021-06-29 | Conversion | 19,763 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2021-03-17 | Grant | 89,934 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2021-03-17 | Grant | 209,846 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Series B Preferred Stock · derivative
|
2021-03-11 | Grant | 19,763 | $5.06 | 100,001 |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2021-01-13 | Grant | 99,753 | $0.00 |